Search research articles
Contact Us
Filters
Showing results (51-60 of 64) with videos related to
Page
of 7
Sort By:
Canadian Journal of Physiology and Pharmacology
|
April 1, 1987
L-641,953 (R-8-fluoro-dibenzo[b, f]thiepin-3-carboxylic acid-5-oxide): a novel thromboxane-prostaglandin endoperoxide antagonist
R A Hall, J R Rokach, P Bélanger, et al.
Prostaglandins, Leukotrienes, and Medicine
|
January 1, 1984
The development of sensitive and specific radioimmunoassays for leukotrienes
J Rokach, E C Hayes, Y Girard, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 1, 1983
Measuring leukotrienes of slow reacting substance of anaphylaxis: development of a specific radioimmunoassay
E C Hayes, D L Lombardo, Y Girard, et al.
British Journal of Pharmacology
|
June 1, 1984
Studies on L-640,035: a novel antagonist of contractile prostanoids in the lung
R Carrier, E J Cragoe, D Ethier, et al.
Progress in Clinical and Biological Research
|
January 1, 1990
A comparison of the efficacy and safety of buserelin vs danazol in the treatment of endometriosis. Protocol 310 Study Group
M Y Dawood, W N Spellacy, W P Dmowski, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 1, 1999
Quinolines as potent 5-lipoxygenase inhibitors: synthesis and biological profile of L-746,530
D Dubé, M Blouin, C Brideau, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 7, 1999
Substituted indoles as potent and orally active 5-lipoxygenase activating protein (FLAP) inhibitors
R Frenette, J H Hutchinson, S Léger, et al.
Physical Review Letters
|
July 22, 2015
Tuning the Magnetic Anisotropy at a Molecule-Metal Interface
K Bairagi, A Bellec, V Repain, et al.
Journal of Medicinal Chemistry
|
July 1, 1983
Synthesis and receptor binding studies relevant to the neuroleptic activities of some 1-methyl-4-piperidylidene-9-substituted-pyrrolo[2,1-b][3]benzazepine derivatives
D C Remy, S F Britcher, S W King, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 5, 1999
2-Pyridinyl-3-(4-methylsulfonyl)phenylpyridines: selective and orally active cyclooxygenase-2 inhibitors
R W Friesen, C Brideau, C C Chan, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 64) with videos related to
Sort By:
Page
of 7
Canadian Journal of Physiology and Pharmacology
|
April 1, 1987
L-641,953 (R-8-fluoro-dibenzo[b, f]thiepin-3-carboxylic acid-5-oxide): a novel thromboxane-prostaglandin endoperoxide antagonist
R A Hall, J R Rokach, P Bélanger, et al.
Prostaglandins, Leukotrienes, and Medicine
|
January 1, 1984
The development of sensitive and specific radioimmunoassays for leukotrienes
J Rokach, E C Hayes, Y Girard, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 1, 1983
Measuring leukotrienes of slow reacting substance of anaphylaxis: development of a specific radioimmunoassay
E C Hayes, D L Lombardo, Y Girard, et al.
British Journal of Pharmacology
|
June 1, 1984
Studies on L-640,035: a novel antagonist of contractile prostanoids in the lung
R Carrier, E J Cragoe, D Ethier, et al.
Progress in Clinical and Biological Research
|
January 1, 1990
A comparison of the efficacy and safety of buserelin vs danazol in the treatment of endometriosis. Protocol 310 Study Group
M Y Dawood, W N Spellacy, W P Dmowski, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 1, 1999
Quinolines as potent 5-lipoxygenase inhibitors: synthesis and biological profile of L-746,530
D Dubé, M Blouin, C Brideau, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 7, 1999
Substituted indoles as potent and orally active 5-lipoxygenase activating protein (FLAP) inhibitors
R Frenette, J H Hutchinson, S Léger, et al.
Physical Review Letters
|
July 22, 2015
Tuning the Magnetic Anisotropy at a Molecule-Metal Interface
K Bairagi, A Bellec, V Repain, et al.
Journal of Medicinal Chemistry
|
July 1, 1983
Synthesis and receptor binding studies relevant to the neuroleptic activities of some 1-methyl-4-piperidylidene-9-substituted-pyrrolo[2,1-b][3]benzazepine derivatives
D C Remy, S F Britcher, S W King, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 5, 1999
2-Pyridinyl-3-(4-methylsulfonyl)phenylpyridines: selective and orally active cyclooxygenase-2 inhibitors
R W Friesen, C Brideau, C C Chan, et al.
Page
of 7